DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update
CUPERTINO, Calif., Nov. 6, 2024 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic…
